The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  H5N1, Crucell ad antibodies Date:  9/18/2007  8:40 PM
Author:  JPG101 Number:  21828 of 25137

Maybe a very novel and obvious way of treating bird flu? The company in question can easily make a lot of this stuff (MAB) for an epidemic.

Anyone interested in Crucell? They seem to be a disruptive force in biomanifacturing.


September 17, 2007
Dutch Drug Firm Crucell Develops Bird Flu Antibody

AMSTERDAM (Reuters) Sept 14 - Dutch biotechnology firm Crucell said on Friday that it has discovered and developed a monoclonal antibody against the deadly H5N1 strain of bird flu. "Using phage display technology a set of human monoclonal antibodies active against a broad range of distinct H5N1 strains was developed," chief scientific officer Jaap Goudsmit said in a statement.

The H5N1 virus remains mainly a virus of birds but experts fear it could change into a form easily transmitted from person to person and sweep the world, killing millions.

So far, most human cases can be traced to direct or indirect contact with infected birds. Globally, the H5N1 virus has killed 195 people out of 322 known cases and hundreds of millions of birds have died or been slaughtered.

Crucell will present pre-clinical studies of the antibody at the International Bird Flu Summit in Las Vegas on Sept. 27-28.
Copyright 1996-2019 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us